European Evidence‐based (S3) Guidelines for the Treatment of Acne
Alexander Nast(Humboldt-Universität zu Berlin), Harald Gollnick(Otto-von-Guericke-Universität Magdeburg), Christos C. Zouboulis(Städtisches Klinikum Dessau), A.Y. Finlay(Cardiff University), Berthold Rzany(Charité - Universitätsmedizin Berlin), J.L. López‐Estebaranz(Hospital Universitario Fundación Alcorcón), Rūta Gancevičienė(Vilnius University), Adel Sammain(Charité - Universitätsmedizin Berlin), Thierry Simonart(IS practice), Alison Layton(Harrogate District Hospital), Stefanie Rosumeck(Charité - Universitätsmedizin Berlin), R. Erdmann(Charité - Universitätsmedizin Berlin), Falk Ochsendorf(University Hospital Frankfurt), Merete Hædersdal(Frederiksberg Hospital), Maja Vurnek Živković(Sisters of Charity Hospital), Cristina Oprica(Karolinska Institutet), Klaus Degitz, Vincenzo Bettoli(University of Ferrara), N. K. Veien, Brigitte Dréno(Inserm)
Journal of the European Academy of Dermatology and Venereology
February 1, 2012
Cited by 422
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
|Clinical and Experimental Dermatology|1994|5.5k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..
|British Journal of Dermatology|1994|1.3k